220 related articles for article (PubMed ID: 18262600)
1. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.
Tilley RE; Holscher T; Belani R; Nieva J; Mackman N
Thromb Res; 2008; 122(5):604-9. PubMed ID: 18262600
[TBL] [Abstract][Full Text] [Related]
2. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
3. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
[TBL] [Abstract][Full Text] [Related]
4. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
5. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
6. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression.
Mayne E; Funderburg NT; Sieg SF; Asaad R; Kalinowska M; Rodriguez B; Schmaier AH; Stevens W; Lederman MM
J Acquir Immune Defic Syndr; 2012 Apr; 59(4):340-6. PubMed ID: 22156911
[TBL] [Abstract][Full Text] [Related]
7. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.
Thaler J; Ay C; Mackman N; Metz-Schimmerl S; Stift J; Kaider A; Müllauer L; Gnant M; Scheithauer W; Pabinger I
Eur J Clin Invest; 2013 Mar; 43(3):277-85. PubMed ID: 23398637
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
11. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-bearing microparticles and cancer.
Zwicker JI
Semin Thromb Hemost; 2008 Mar; 34(2):195-8. PubMed ID: 18645925
[TBL] [Abstract][Full Text] [Related]
13. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
15. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
[TBL] [Abstract][Full Text] [Related]
16. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.
Diamant M; Nieuwland R; Pablo RF; Sturk A; Smit JW; Radder JK
Circulation; 2002 Nov; 106(19):2442-7. PubMed ID: 12417540
[TBL] [Abstract][Full Text] [Related]
17. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
18. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
20. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]